Anadolu Medical Center
Pancreatic neuroendocrine tumors treatment cost in Turkey typically ranges from AUD $6,881 to AUD $14,766 for non-invasive options like CyberKnife, while more complex interventions like NanoKnife run from AUD $13,619 to AUD $22,220. Total expenses depend on the tumor stage and the specific surgical approach required. Australian patients generally save between 40% and 60% compared to local private healthcare prices. Istanbul and Antalya are the primary hubs for these specialised procedures.
Typical Pancreatic Neuroendocrine Tumors Treatment Costs in Turkey
Bookimed Expert Insight: Patients requiring advanced nuclear medicine benefit from the high-volume expertise at Medipol Mega University Hospital. This centre handles over 1,000 patients daily and provides rarer targeted options like Actinium-225. For complex surgical cases, Anadolu Medical Center offers treatment following U.S. protocols. This is possible through its official affiliation with Johns Hopkins Hospital. Specialist doctors like Professor Yesim Yildirim bring over 20 years of oncology experience to these multidisciplinary teams.
| Turkey | Thailand | South Korea | |
| NanoKnife | from AUD $13,619 | from AUD $15,769 | from AUD $25,088 |
| CyberKnife | from AUD $6,810 | from AUD $43,007 | from AUD $16,486 |
| Enucleation of tumor on pancreas | from AUD $14,336 | - | - |
| Actinium-225 Therapy | from AUD $32,908 | from AUD $35,839 | - |
Professor Bulent Karagoz is a leading medical oncologist at Anadolu Medical Center, specialising in tumor immunology and targeted therapies for complex cancers.
Associate Professor Mustafa Solak has managed over 1,100 cancer treatments and trained at the MD Anderson Cancer Center – one of the world's highest-ranked oncology hospitals.
Associate Professor Eda Tanrikulu is a high-achieving medical oncologist at Anadolu Medical Center who ranked third in Turkey's prestigious national specialist entrance exams.
Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.